Comparison of the efficacy and safety of arformoterol 15 μg twice daily and arformoterol 30 μg once daily in COPD: A single-dose, multicenter, randomized, modified-blind, two-way crossover study
Titel:
Comparison of the efficacy and safety of arformoterol 15 μg twice daily and arformoterol 30 μg once daily in COPD: A single-dose, multicenter, randomized, modified-blind, two-way crossover study
Auteur:
Panettieri Jr., Reynold A. MacIntyre, Neil Sims, Michael Kerwin, Edward Fogarty, Charles Noonan, Michael Claus, Raymond Andrews, William T.